Dan Leonard
Stock Analyst at UBS
(4.09)
# 475
Out of 5,072 analysts
308
Total ratings
57.47%
Success rate
9.59%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $180 | $154.90 | +16.20% | 23 | Nov 25, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $13 → $14 | $18.73 | -25.25% | 7 | Nov 7, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $70 | $64.54 | +8.46% | 12 | Nov 6, 2025 | |
| BRKR Bruker | Maintains: Neutral | $40 → $43 | $48.84 | -11.96% | 12 | Nov 4, 2025 | |
| GH Guardant Health | Maintains: Buy | $80 → $110 | $106.85 | +2.95% | 11 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $225 → $250 | $229.68 | +8.85% | 17 | Oct 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $590 | $593.15 | -0.53% | 18 | Oct 23, 2025 | |
| EXAS Exact Sciences | Maintains: Neutral | $61 → $53 | $101.53 | -47.80% | 10 | Aug 7, 2025 | |
| CERT Certara | Maintains: Buy | $18 → $15 | $9.16 | +63.76% | 10 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $300 → $305 | $608.28 | -49.86% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $225 | $227.95 | -1.29% | 18 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,530 → $1,350 | $1,484.01 | -9.03% | 9 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $328.79 | -5.71% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $336.48 | -7.87% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $104.48 | +10.07% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $96.46 | +2.63% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $11.67 | +114.22% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $177.62 | +4.15% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $9.60 | -6.25% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $30.07 | +16.40% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $130.32 | +53.47% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $3.64 | +202.20% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $238.18 | -70.61% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $19.63 | -64.34% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $404.94 | -14.80% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $179.81 | +44.60% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $190.46 | -23.87% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $74.76 | +20.39% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $48.50 | +31.24% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $268.88 | +26.45% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $22.88 | +4.90% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $7.68 | +355.73% | 12 | Aug 14, 2019 |
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $170 → $180
Current: $154.90
Upside: +16.20%
10x Genomics
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $14
Current: $18.73
Upside: -25.25%
Bio-Techne
Nov 6, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $64.54
Upside: +8.46%
Bruker
Nov 4, 2025
Maintains: Neutral
Price Target: $40 → $43
Current: $48.84
Upside: -11.96%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $80 → $110
Current: $106.85
Upside: +2.95%
IQVIA Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $225 → $250
Current: $229.68
Upside: +8.85%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $590
Current: $593.15
Upside: -0.53%
Exact Sciences
Aug 7, 2025
Maintains: Neutral
Price Target: $61 → $53
Current: $101.53
Upside: -47.80%
Certara
Aug 7, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $9.16
Upside: +63.76%
Medpace Holdings
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $608.28
Upside: -49.86%
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $227.95
Upside: -1.29%
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,484.01
Upside: -9.03%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $328.79
Upside: -5.71%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $336.48
Upside: -7.87%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $104.48
Upside: +10.07%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $96.46
Upside: +2.63%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $11.67
Upside: +114.22%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $177.62
Upside: +4.15%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $9.60
Upside: -6.25%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $30.07
Upside: +16.40%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $130.32
Upside: +53.47%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $3.64
Upside: +202.20%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $238.18
Upside: -70.61%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $19.63
Upside: -64.34%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $404.94
Upside: -14.80%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $179.81
Upside: +44.60%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $190.46
Upside: -23.87%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $74.76
Upside: +20.39%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $48.50
Upside: +31.24%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $268.88
Upside: +26.45%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $22.88
Upside: +4.90%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $7.68
Upside: +355.73%